ExpressPoints: Transforming the Treatment Paradigm for Patients With MDS

Download this brief summary slide set from a live CCO presentation on optimal management of patients with myelodysplastic syndromes.
Guillermo Garcia-Manero, MD
Rami S. Komrokji, MD
Jamile Shammo, MD, FASCP, FACP
Format: Microsoft PowerPoint (.ppt)
File Size: 1.47 MB
Released: December 21, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Taiho Oncology Inc.

Related Content

Expert text module that provides insights from a leading patient advocate/healthcare professional on best practices in education for patients with CLL, from Clinical Care Options (CCO)

Nichole Fisher Headshot Nichole Fisher, RN, BSN Brian Koffman, MDCM (retired), MS Ed Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: August 17, 2022 Expired: August 16, 2023

Comentario experto de los datos de la EHA 2022 sobre inhibidores de la QBT para LLC y LCM de Clinical Care Options (CCO)

Othman Al-Sawaf, MD Lydia Scarfò, MD Released: August 15, 2022

Expertengespräch über die Daten der EHA 2022 zu BTK-Inhibitoren für CLL und MCL, von Clinical Care Options (CCO)

Othman Al-Sawaf, MD Lydia Scarfò, MD Released: August 15, 2022

Comentários de especialistas sobre dados do EHA 2022 sobre os inibidores de BTK para LLC e LCM, do Clinical Care Options (CCO)

Othman Al-Sawaf, MD Lydia Scarfò, MD Released: August 15, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings